Metalloproteinases as Targets for Anti-Inflammatory Drugs / Progress in Inflammation Research (PDF)
(Sprache: Englisch)
This volume describes recent research in the field of metalloproteinases (a family of enzymes that can catalyze tissue degradation), in particular their participation in autoimmune diseases such as rheumatoid arthritis, reviewing the latest developments in...
sofort als Download lieferbar
eBook (pdf)
213.99 €
106 DeutschlandCard Punkte sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „Metalloproteinases as Targets for Anti-Inflammatory Drugs / Progress in Inflammation Research (PDF)“
This volume describes recent research in the field of metalloproteinases (a family of enzymes that can catalyze tissue degradation), in particular their participation in autoimmune diseases such as rheumatoid arthritis, reviewing the latest developments in metalloproteinase inhibitor design and the current status of clinical candidates. This volume is intended not only for those active in research into metalloproteinases but also for those with an interest in inflammatory diseases. Thus it addresses both academic and industrial researchers.
Bibliographische Angaben
- 2012, 1999, 207 Seiten, Englisch
- Herausgegeben: Kevin M. K. Bottomley, David Bradshaw, John S. Nixon
- Verlag: Birkhäuser Basel
- ISBN-10: 3034886667
- ISBN-13: 9783034886666
- Erscheinungsdatum: 06.12.2012
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Größe: 28 MB
- Ohne Kopierschutz
- Vorlesefunktion
Sprache:
Englisch
Kommentar zu "Metalloproteinases as Targets for Anti-Inflammatory Drugs / Progress in Inflammation Research"
0 Gebrauchte Artikel zu „Metalloproteinases as Targets for Anti-Inflammatory Drugs / Progress in Inflammation Research“
Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
---|
Schreiben Sie einen Kommentar zu "Metalloproteinases as Targets for Anti-Inflammatory Drugs / Progress in Inflammation Research".
Kommentar verfassen